CN101977628A - α7烟碱激动剂和抗精神病药的组合 - Google Patents
α7烟碱激动剂和抗精神病药的组合 Download PDFInfo
- Publication number
- CN101977628A CN101977628A CN2009801102033A CN200980110203A CN101977628A CN 101977628 A CN101977628 A CN 101977628A CN 2009801102033 A CN2009801102033 A CN 2009801102033A CN 200980110203 A CN200980110203 A CN 200980110203A CN 101977628 A CN101977628 A CN 101977628A
- Authority
- CN
- China
- Prior art keywords
- methyl
- azabicyclo
- oct
- pyridine radicals
- urea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CCN(C)C(C(*C(*[Al])=*)C(C)C)C=P Chemical compound CCN(C)C(C(*C(*[Al])=*)C(C)C)C=P 0.000 description 2
- OXKRFEWMSWPKKV-UHFFFAOYSA-N O=C(c1cc2ccccc2[o]1)NC1C(CC2)CCN2C1Cc1cnccc1 Chemical compound O=C(c1cc2ccccc2[o]1)NC1C(CC2)CCN2C1Cc1cnccc1 OXKRFEWMSWPKKV-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2828208P | 2008-02-13 | 2008-02-13 | |
| US61/028,282 | 2008-02-13 | ||
| PCT/US2009/034062 WO2009102962A2 (en) | 2008-02-13 | 2009-02-13 | Combination of alpha 7 nicotinic agonists and antipsychotics |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013100500436A Division CN103143023A (zh) | 2008-02-13 | 2009-02-13 | α7烟碱激动剂和抗精神病药的组合 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101977628A true CN101977628A (zh) | 2011-02-16 |
Family
ID=40902222
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009801102033A Pending CN101977628A (zh) | 2008-02-13 | 2009-02-13 | α7烟碱激动剂和抗精神病药的组合 |
| CN2013100500436A Pending CN103143023A (zh) | 2008-02-13 | 2009-02-13 | α7烟碱激动剂和抗精神病药的组合 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013100500436A Pending CN103143023A (zh) | 2008-02-13 | 2009-02-13 | α7烟碱激动剂和抗精神病药的组合 |
Country Status (25)
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107469087A (zh) * | 2017-09-10 | 2017-12-15 | 孙永丽 | 用于治疗精神病的制剂 |
| CN108727416A (zh) * | 2017-04-20 | 2018-11-02 | 北京大学 | 三环杂芳香体系酰胺衍生物及其制备和用途 |
| CN117480169A (zh) * | 2021-01-08 | 2024-01-30 | 艾福姆德尤股份有限公司 | 用于治疗与sting活性有关的疾病的化合物和组合物 |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8314119B2 (en) * | 2006-11-06 | 2012-11-20 | Abbvie Inc. | Azaadamantane derivatives and methods of use |
| SA08290475B1 (ar) * | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
| EP2619205B1 (en) | 2010-09-23 | 2017-05-17 | AbbVie Bahamas Ltd. | Monohydrate of an azaadamantane derivative |
| EP2665478A1 (en) * | 2011-01-18 | 2013-11-27 | Targacept, Inc. | Treatment of cognitive dysfunction in schizophrenia |
| US9139576B2 (en) | 2011-05-03 | 2015-09-22 | Merck Sharp & Dohme Corp. | Aminomethyl biaryl benzotriazole derivatives |
| MX2015004285A (es) * | 2012-10-02 | 2015-08-06 | Sumitomo Dainippon Pharma Co Ltd | Derivado de imidazol. |
| JP6807094B2 (ja) * | 2016-04-29 | 2021-01-06 | 国立大学法人秋田大学 | クロザピン又はその誘導体の血中薬剤濃度上昇リスク判定方法及び薬剤投与量判定方法 |
| CN110087641B (zh) | 2016-12-20 | 2024-03-12 | 罗曼治疗系统股份公司 | 含有阿塞那平和聚硅氧烷或聚异丁烯的透皮治疗系统 |
| PL3338768T3 (pl) | 2016-12-20 | 2020-05-18 | Lts Lohmann Therapie-Systeme Ag | Transdermalny system terapeutyczny zawierający asenapinę |
| JP2020525545A (ja) | 2017-06-26 | 2020-08-27 | エルテーエス ローマン テラピー−ジステーメ アーゲー | アセナピンおよびシリコーンアクリルハイブリッドポリマーを含有する経皮治療システム |
| CN118806732A (zh) | 2018-06-20 | 2024-10-22 | 罗曼治疗系统股份公司 | 含有阿塞那平的透皮治疗系统 |
| BR112020026099A2 (pt) | 2018-06-20 | 2021-03-23 | Lts Lohmann Therapie-Systeme Ag | sistema terapêutico transdérmico que contém asenapina |
| JP2024502474A (ja) | 2021-01-08 | 2024-01-19 | アイエフエム デュー インコーポレイテッド | Sting活性に関連する状態を治療するための、尿素を有するヘテロ二環式化合物または類似体およびその組成物 |
| DE102022114269A1 (de) | 2022-06-07 | 2023-12-07 | Rational Aktiengesellschaft | Gargerät mit einem Selbstreinigungssystem sowie ein Verfahren zum Ändern von Reinigungsparametern für das Gargerät |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6953855B2 (en) * | 1998-12-11 | 2005-10-11 | Targacept, Inc. | 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| US7309699B2 (en) * | 2003-12-22 | 2007-12-18 | Abbott Laboratories | 3-Quinuclidinyl amino-substituted biaryl derivatives |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5597919A (en) * | 1995-01-06 | 1997-01-28 | Dull; Gary M. | Pyrimidinyl or Pyridinyl alkenyl amine compounds |
| US5712270A (en) | 1995-11-06 | 1998-01-27 | American Home Products Corporation | 2-arylamidothiazole derivatives with CNS activity |
| US5616716A (en) * | 1996-01-06 | 1997-04-01 | Dull; Gary M. | (3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds |
| SE9600683D0 (sv) | 1996-02-23 | 1996-02-23 | Astra Ab | Azabicyclic esters of carbamic acids useful in therapy |
| US5663356A (en) * | 1996-04-23 | 1997-09-02 | Ruecroft; Graham | Method for preparation of aryl substituted alefinic secondary amino compounds |
| AR013184A1 (es) | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
| AU765142B2 (en) | 1998-06-01 | 2003-09-11 | Ortho-Mcneil Pharmaceutical, Inc. | Method for treating neurodegenerative disorders |
| SE9904176D0 (sv) | 1999-11-18 | 1999-11-18 | Astra Ab | New use |
| BR0016168A (pt) * | 1999-12-10 | 2002-08-20 | Combinações terapêuticas de (s)-2-(benzilaminometil)-2,3,8,9tetrahidro-7h-1,4-dioxi no[2,3 -e]indol-8-ona e neurolépticos para o tratamento ou prevenção de distúrbios psicóticos | |
| AU2001266100B9 (en) * | 2000-06-27 | 2005-10-06 | Laboratorios S.A.L.V.A.T., S.A. | Carbamates derived from arylalkylamines |
| US6486172B2 (en) | 2000-08-18 | 2002-11-26 | Pharmacia & Upjohn Company | Quinuclidine-substituted aryl compounds for treatment of disease |
| US6492386B2 (en) | 2000-08-18 | 2002-12-10 | Pharmacia & Upjohn Company | Quinuclidine-substituted aryl compounds for treatment of disease |
| AU2001282874A1 (en) | 2000-08-18 | 2002-03-04 | Pharmacia And Upjohn Company | Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) |
| WO2002017358A2 (en) | 2000-08-21 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists) |
| WO2002015662A2 (en) | 2000-08-21 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists |
| JP2004506734A (ja) | 2000-08-21 | 2004-03-04 | ファルマシア・アンド・アップジョン・カンパニー | 疾患治療用のキヌクリド置換ヘテロアリール部分 |
| US6554086B1 (en) * | 2000-10-27 | 2003-04-29 | Invacare Corporation | Obstacle traversing wheelchair |
| EP1345937B1 (en) | 2000-12-22 | 2005-09-28 | Almirall Prodesfarma AG | Quinuclidine carbamate derivatives and their use as m3 antagonists |
| CA2476624A1 (en) * | 2002-02-19 | 2003-08-28 | Pharmacia & Upjohn Company | Azabicyclic compounds for the treatment of disease |
| JP2006510664A (ja) * | 2002-12-06 | 2006-03-30 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 1−アザビシクロ[2.2.2]オクト置換フロ[2,3−c]ピリジニルカルボキサミドの結晶性フマル酸塩及び該塩を含む組成物並びにその製造方法 |
| TW200502222A (en) * | 2003-04-02 | 2005-01-16 | Novartis Ag | Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders |
| WO2004099202A1 (en) * | 2003-05-05 | 2004-11-18 | Pharmacia & Upjohn Company Llc | Quinuclidines substituted bentodioxine carboxamides for the treatment of neurodegenerative diseases |
| EP1699488A2 (en) * | 2003-12-23 | 2006-09-13 | Pfizer Products Incorporated | Therapeutic combination for cognition enhancement and psychotic disorders |
| EP1863485A2 (en) * | 2005-03-18 | 2007-12-12 | Abbott Laboratories | Alpha7 neuronal nicotinic receptor ligand and antipsychotic compositions |
-
2009
- 2009-02-13 EP EP09709577.2A patent/EP2254598B1/en active Active
- 2009-02-13 DK DK09709577.2T patent/DK2254598T3/da active
- 2009-02-13 NZ NZ587312A patent/NZ587312A/en not_active IP Right Cessation
- 2009-02-13 PT PT97095772T patent/PT2254598E/pt unknown
- 2009-02-13 SG SG2013010327A patent/SG188144A1/en unknown
- 2009-02-13 CA CA2715268A patent/CA2715268A1/en not_active Abandoned
- 2009-02-13 EP EP13167089.5A patent/EP2633868A1/en not_active Withdrawn
- 2009-02-13 HR HRP20130749AT patent/HRP20130749T1/hr unknown
- 2009-02-13 AU AU2009214625A patent/AU2009214625A1/en not_active Abandoned
- 2009-02-13 RU RU2010137787/15A patent/RU2481123C2/ru not_active IP Right Cessation
- 2009-02-13 MX MX2010008875A patent/MX2010008875A/es not_active Application Discontinuation
- 2009-02-13 SI SI200930714T patent/SI2254598T1/sl unknown
- 2009-02-13 CN CN2009801102033A patent/CN101977628A/zh active Pending
- 2009-02-13 KR KR1020107020088A patent/KR20100113163A/ko not_active Ceased
- 2009-02-13 RS RS20130387A patent/RS52941B/sr unknown
- 2009-02-13 US US12/867,073 patent/US20110059947A1/en not_active Abandoned
- 2009-02-13 PL PL09709577T patent/PL2254598T3/pl unknown
- 2009-02-13 BR BRPI0907570A patent/BRPI0907570A2/pt not_active IP Right Cessation
- 2009-02-13 WO PCT/US2009/034062 patent/WO2009102962A2/en not_active Ceased
- 2009-02-13 JP JP2010546920A patent/JP2011511845A/ja active Pending
- 2009-02-13 CN CN2013100500436A patent/CN103143023A/zh active Pending
- 2009-02-13 ES ES09709577T patent/ES2430622T3/es active Active
-
2010
- 2010-08-03 IL IL207389A patent/IL207389A0/en unknown
- 2010-08-23 ZA ZA2010/05999A patent/ZA201005999B/en unknown
- 2010-09-09 EC EC2010010471A patent/ECSP10010471A/es unknown
- 2010-09-10 CO CO10112124A patent/CO6290706A2/es not_active Application Discontinuation
-
2013
- 2013-10-10 CY CY20131100896T patent/CY1114492T1/el unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6953855B2 (en) * | 1998-12-11 | 2005-10-11 | Targacept, Inc. | 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| US7309699B2 (en) * | 2003-12-22 | 2007-12-18 | Abbott Laboratories | 3-Quinuclidinyl amino-substituted biaryl derivatives |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108727416A (zh) * | 2017-04-20 | 2018-11-02 | 北京大学 | 三环杂芳香体系酰胺衍生物及其制备和用途 |
| CN108727416B (zh) * | 2017-04-20 | 2021-03-09 | 北京大学 | 三环杂芳香体系酰胺衍生物及其制备和用途 |
| CN107469087A (zh) * | 2017-09-10 | 2017-12-15 | 孙永丽 | 用于治疗精神病的制剂 |
| CN117480169A (zh) * | 2021-01-08 | 2024-01-30 | 艾福姆德尤股份有限公司 | 用于治疗与sting活性有关的疾病的化合物和组合物 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009102962A2 (en) | 2009-08-20 |
| PL2254598T3 (pl) | 2013-12-31 |
| EP2254598B1 (en) | 2013-07-10 |
| JP2011511845A (ja) | 2011-04-14 |
| IL207389A0 (en) | 2010-12-30 |
| PT2254598E (pt) | 2013-10-16 |
| SG188144A1 (en) | 2013-03-28 |
| CO6290706A2 (es) | 2011-06-20 |
| ES2430622T3 (es) | 2013-11-21 |
| RS52941B (sr) | 2014-02-28 |
| WO2009102962A3 (en) | 2009-10-08 |
| HRP20130749T1 (en) | 2013-10-11 |
| AU2009214625A1 (en) | 2009-08-20 |
| SI2254598T1 (sl) | 2013-10-30 |
| RU2010137787A (ru) | 2012-03-20 |
| EP2254598A2 (en) | 2010-12-01 |
| ZA201005999B (en) | 2011-05-25 |
| NZ587312A (en) | 2011-12-22 |
| KR20100113163A (ko) | 2010-10-20 |
| ECSP10010471A (es) | 2010-10-30 |
| MX2010008875A (es) | 2010-08-31 |
| DK2254598T3 (da) | 2013-07-29 |
| CA2715268A1 (en) | 2009-08-20 |
| BRPI0907570A2 (pt) | 2019-09-24 |
| CN103143023A (zh) | 2013-06-12 |
| HK1147954A1 (en) | 2011-08-26 |
| RU2481123C2 (ru) | 2013-05-10 |
| US20110059947A1 (en) | 2011-03-10 |
| EP2633868A1 (en) | 2013-09-04 |
| CY1114492T1 (el) | 2016-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2254598B1 (en) | Combination of alpha 7 nicotinic agonists and antipsychotics | |
| Dwomoh et al. | Targeting the M1 muscarinic acetylcholine receptor in Alzheimer’s disease | |
| JP7082186B2 (ja) | プリドピジンによる筋萎縮性側索硬化症の治療方法 | |
| US20220202798A1 (en) | Use of pridopidine for the treatment of fragile x syndrome | |
| US20100178277A1 (en) | Methods and compositions for stimulating cells | |
| KR20190124722A (ko) | 신경계 장애의 치료에서 사용하기 위한 d-메타돈 및 이의 유도체 | |
| EP3606525B1 (en) | Compositions for treating aging-associated impairments using ccr3-inhibitors | |
| AU2021200697A1 (en) | Use of pridopidine for the treatment of anxiety and depression | |
| US20070293538A1 (en) | Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders | |
| JP2018520187A (ja) | 神経変性疾患と関連する幻覚の予防および処置のために有用な5−ht2aセロトニン受容体のモジュレーターとしてのジアリールおよびアリールヘテロアリール尿素誘導体 | |
| WO2021016369A1 (en) | Pimavanserin for trating schizophrenia or for treating psychosis secondary to neurodegenerative disorders or depressive disorder | |
| Chagraoui et al. | 5-HT6 receptors: Contemporary views on their neurobiological and pharmacological relevance in neuropsychiatric disorders | |
| JP2022511266A (ja) | 陰性症状および障害を処置するため、神経可塑性を増大するため、ならびに神経保護を促進するためのロルペリドンの使用 | |
| CN102365269A (zh) | 用于治疗认知缺损的新药物 | |
| Ding et al. | Ketamine as a rapid-acting antidepressant: A scoping review of mechanisms and efficacy in treatment-resistant depression | |
| HK1185794A (en) | Combination of alpha 7 nicotinic agonists and antipsychotics | |
| HK1147954B (en) | Combination of alpha 7 nicotinic agonists and antipsychotics | |
| JP5714572B2 (ja) | 精神障害およびその症状の治療のためのkcnqカリウムチャネル活性の調節方法 | |
| ES3062815T3 (en) | Compositions for treating aging-associated impairments using ccr3-inhibitors | |
| Hori | Developmental Effects of Bilateral Ventral Hippocampal Lesions on Neocortical [capital Delta] FosB Expression and Cognition: Reversal of Cognitive Deficits by Darbepoetin Alfa But Not Clozapine | |
| Goff et al. | Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20110216 |